1.Griffin J, McPhaul M, Russell D, Wilson J 1995 The androgen resistance syndrome: Steroid 5α-reductase 2 deficiency, testicular feminization, and related disordes. In: Scriver CR BA, Sly WS, Vale D (ed) The metabolic and molecular bases of inherited disease, 7th ed. McGraw-Hill, New York, pp 2967-
2.Swain A, Lovell-Badge R 1999 Mammalian sex determination: a molecular drama. Genes Dev 13:755-67.
3.Hammes A, Guo JK, Lutsch G, et al. 2001 Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106:319-29.
4.Parker KL 1998 The roles of steroidogenic factor 1 in endocrine development and function. Mol Cell Endocrinol 140:59-63.
5.Parker KL, Schedl A, Schimmer BP 1999 Gene interactions in gonadal development. Annu Rev Physiol 61:417-33
6.Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB 1993 The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40:85-97
7.Wilhelm D, Englert C 2002 The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev 16:1839-51
8.Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-90.
9.De Santa Barbara P, Bonneaud N, Boizet B, et al. 1998 Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 18:6653-65
10.Giuili G, Shen WH, Ingraham HA 1997 The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo. Development 124:1799-807.
11.Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA 1998 Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93:445-54
12.Katoh-Fukui Y, Tsuchiya R, Shiroishi T, et al. 1998 Male-to-female sex reversal in M33 mutant mice. Nature 393:688-92
13.Birk OS, Casiano DE, Wassif CA, et al. 2000 The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 403:909-13
14.Ottolenghi C, Moreira-Filho C, Mendonca BB, et al. 2001 Absence of mutations involving the LIM homeobox domain gene LHX9 in 46,XY gonadal agenesis and dysgenesis. J Clin Endocrinol Metab 86:2465-9.
15.Quaggin SE, Schwartz L, Cui S, et al. 1999 The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126:5771-83
16.Cui S, Ross A, Stallings N, Parker KL, Capel B, Quaggin SE 2004 Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 131:4095-105
17.Raymond CS, Murphy MW, O'Sullivan MG, Bardwell VJ, Zarkower D 2000 Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev 14:2587-95
18.Bowles J, Bullejos M, Koopman P 2000 A subtractive gene expression screen suggests a role for vanin-1 in testis development in mice. Genesis 27:124-35
19.Berta P, Hawkins JR, Sinclair AH, et al. 1990 Genetic evidence equating SRY and the testis-determining factor. Nature 348:448-50.
20.Sinclair AH, Berta P, Palmer MS, et al. 1990 A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240-4.
21.Giese K, Pagel J, Grosschedl R 1994 Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc Natl Acad Sci U S A 91:3368-72.
22.Canning CA, Lovell-Badge R 2002 Sry and sex determination: how lazy can it be? Trends Genet 18:111-3.
23.Yao HH, Whoriskey W, Capel B 2002 Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev 16:1433-40
24.Colvin JS GR, Schmahl J, Capel B, Ornitz DM 2001 Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104:875-89
25.Ross AJ, Tilman C, Yao H, MacLaughlin D, Capel B 2003 AMH induces mesonephric cell migration in XX gonads. Mol Cell Endocrinol 211:1-7
26.Hanley NA, Hagan DM, Clement-Jones M, et al. 2000 SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech Dev 91:403-7.
27.Vidal VP, Chaboissier MC, de Rooij DG, Schedl A 2001 Sox9 induces testis development in XX transgenic mice. Nat Genet 28:216-7.
28.Morais da Silva S, Hacker A, Harley V, Goodfellow P, Swain A, Lovell-Badge R 1996 Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 14:62-8
29.Park SY JJ 2004 TRANSCRIPTIONAL REGULATION OF GONADAL DEVELOPMENT AND DIFFERENTIATION. Endocrinology. Dec 16; [Epub ahead of print].
30.Chaboissier MC KA, Vidal VI, Lutzkendorf S, van de Kant HJ, Wegner M, de Rooij DG, Behringer RR, Schedl A. 2004 Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development. ;131(9):1891-901).
31.Tevosian SG, Albrecht KH, Crispino JD, Fujiwara Y, Eicher EM, Orkin SH 2002 Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Development 129:4627-34
32.Nef S, Verma-Kurvari S, Merenmies J, et al. 2003 Testis determination requires insulin receptor family function in mice. Nature 426:291-5
33.Meeks JJ WJ, Jameson JL 2003 Dax1 is required for testis determination. Nat Genet 34:32-3).
34.Grumbach M, Hughes I.A., Conte FC 2003 Disorders of sexual differentiation. In: al.) RLe (ed) Williams Textbook of endocrinology, 10th ed. Saunders, Philadelfia, pp 842-1002
35.Josso N, Briard ML 1980 Embryonic testicular regression syndrome: variable phenotypic expression in siblings. J Pediatr 97:200-4.
36.Chemke J, Carmichael R, Stewart JM, Geer RH, Robinson A 1970 Familial XY gonadal dysgenesis. J Med Genet 7:105-11
37.Swyer GI 1955 Male pseudohermaphroditism: a hitherto undescribed form. Br Med J:709-12
38.Simpson JL, Blagowidow N, Martin AO 1981 XY gonadal dysgenesis: genetic heterogeneity based upon clinical observations, H-Y antigen status and segregation analysis. Hum Genet 58:91-7
39.Allard S, Cadotte M, Boivin Y 1972 [Pure familial gonadal dysgenesis and gonadoblastoma]. Union Med Can 101:448-52
40.Nazareth HR, Moreira-Filho CA, Cunha AJ, Vieira-Filho JP, Lengyel AM, Lima MC 1979 H-Y antigen in 46,XY pure testicular dysgenesis. Am J Med Genet 3:149-54
41.Vilain E, Elreavey KM, Richaud F, Fellous M 1992 [Sex genetics]. Presse Med 21:852-6.
42.Hawkins JR 1993 Mutational analysis of SRY in XY females. Hum Mutat 2:347-50
43.McElreavey K, Vilain E, Barbaux S, et al. 1996 Loss of sequences 3' to the testis-determining gene, SRY, including the Y pseudoautosomal boundary associated with partial testicular determination. Proc Natl Acad Sci U S A 93:8590-4
44.Vilain E, McElreavey K, Jaubert F, Raymond JP, Richaud F, Fellous M 1992 Familial case with sequence variant in the testis-determining region associated with two sex phenotypes. Am J Hum Genet 50:1008-11
45.Harley VR, Jackson DI, Hextall PJ, et al. 1992 DNA binding activity of recombinant SRY from normal males and XY females. Science 255:453-6.
46.Schmitt-Ney M, Thiele H, Kaltwasser P, Bardoni B, Cisternino M, Scherer G 1995 Two novel SRY missense mutations reducing DNA binding identified in XY females and their mosaic fathers. Am J Hum Genet 56:862-9.
47.Domenice S, Yumie Nishi M, Correia Billerbeck AE, et al. 1998 A novel missense mutation (S18N) in the 5' non-HMG box region of the SRY gene in a patient with partial gonadal dysgenesis and his normal male relatives. Hum Genet 102:213-5.
48.Bardoni B, Zanaria E, Guioli S, et al. 1994 A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 7:497-501.
49.German J, Simpson JL, Chaganti RS, Summitt RL, Reid LB, Merkatz IR 1978 Genetically determined sex-reversal in 46,XY humans. Science 202:53-6.
50.Ludbrook LM, Harley VR 2004 Sex determination: a 'window' of DAX1 activity. Trends Endocrinol Metab 15:116-21
51.Sarto GE, Opitz JM 1973 The XY gonadal agenesis syndrome. J Med Genet 10:288-93.
52.Cleary RE, Caras J, Rosenfield RL, Young PC 1977 Endocrine and metabolic studies in a patient with male pseudohermaphroditism and true agonadism. Am J Obstet Gynecol 128:862-7.
53.De Marchi M, Campagnoli C, Ghiringhello B, Ponzio G, Carbonara A 1981 Gonadal agenesis in a phenotypically normal female with positive H-Y antigen. Hum Genet 56:417-9
54.Mendonca BB, Barbosa AS, Arnhold IJ, McElreavey K, Fellous M, Moreira-Filho CA 1994 Gonadal agenesis in XX and XY sisters: evidence for the involvement of an autosomal gene. Am J Med Genet 52:39-43
55.Lala DS, Rice DA, Parker KL 1992 Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 6:1249-58.
56.Ingraham HA, Lala DS, Ikeda Y, et al. 1994 The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8:2302-12
57.Achermann JC, Ito M, Hindmarsh PC, Jameson JL 1999 A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-6.
58.Achermann JC, Ozisik G, Ito M, et al. 2002 Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87:1829-33.
59.Correa RV DS, Bingham NC, Billerbeck AE, Rainey WE, Parker KL, Mendonca BB. 2004 A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab. 89(4):1767-72.).)
60.Hammer GD, Ingraham HA 1999 Steroidogenic factor-1: its role in endocrine organ development and differentiation. Front Neuroendocrinol 20:199-223.
61.Mallet D, Bretones P, Michel-Calemard L, Dijoud F, David M, Morel Y 2004 Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. J Clin Endocrinol Metab 89:4829-32
62.Hasegawa T FM, Sato N, Katsumata N, Sasaki G, Fukutani K, Morohashi K-I, Ogata T. 2004 Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab. 89(12):5930-5.).
63.Jameson JL 2004 Of mice and men: The tale of steroidogenic factor-1. J Clin Endocrinol Metab 89:5927-9
64.Stark K, Vainio S, Vassileva G, McMahon AP 1994 Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679-83.
65.Gavin BJ, McMahon JA, McMahon AP 1990 Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev 4:2319-32.
66.Elejalde BR, Opitz JM, de Elejalde MM, et al. 1984 Tandem dup (1p) within the short arm of chromosome 1 in a child with ambiguous genitalia and multiple congenital anomalies. Am J Med Genet 17:723-30
67.Jordan BK, Mohammed M, Ching ST, et al. 2001 Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet 68:1102-9
68.Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP 1999 Female development in mammals is regulated by Wnt-4 signalling. Nature 397:405-9
69.Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ 2004 A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351:792-8
70.Jeays-Ward K, Dandonneau M, Swain A 2004 Wnt4 is required for proper male as well as female sexual development. Dev Biol 276:431-40
71.Raymond CS, Parker ED, Kettlewell JR, et al. 1999 A region of human chromosome 9p required for testis development contains two genes related to known sexual regulators. Hum Mol Genet 8:989-96
72.Raymond CS, Shamu CE, Shen MM, et al. 1998 Evidence for evolutionary conservation of sex-determining genes. Nature 391:691-5
73.Muroya K, Okuyama T, Goishi K, et al. 2000 Sex-determining gene(s) on distal 9p: clinical and molecular studies in six cases. J Clin Endocrinol Metab 85:3094-100
74.Ounap K UO, Zordania R, Kiho L, Oiglane-Shlik E, Batsch O 2004 Three patients with XY complement, bilateral ovotestes, and extreme growth retardation, and two XX female with normal pubertal. Am J Med Genet, 130A(4): 415-23).
75.Stayton CL, Dabovic B, Gulisano M, et al. 1994 Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. Hum Mol Genet 3:1957-64.
76.Gibbons RJ, Brueton L, Buckle VJ, et al. 1995 Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet 55:288-99
77.Gibbons RJ, Higgs DR 2000 Molecular-clinical spectrum of the ATR-X syndrome. Am J Med Genet 97:204-12.
78.Wilkie AO, Gibbons RJ, Higgs DR, Pembrey ME 1991 X linked alpha thalassaemia/mental retardation: spectrum of clinical features in three related males. J Med Genet 28:738-41.
79.Riccardi VM, Sujansky E, Smith AC, Francke U 1978 Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 61:604-10
80.van Heyningen V, Bickmore WA, Seawright A, et al. 1990 Role for the Wilms tumor gene in genital development? Proc Natl Acad Sci U S A 87:5383-6
81.Mueller RF 1994 The Denys-Drash syndrome. J Med Genet 31:471-7
82.Baird PN, Santos A, Groves N, Jadresic L, Cowell JK 1992 Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1:301-5
83.Bruening W, Bardeesy N, Silverman BL, et al. 1992 Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet 1:144-8.
84.Pelletier J, Bruening W, Kashtan CE, et al. 1991 Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-47.
85.Drash A, Sherman F, Hartmann WH, Blizzard RM 1970 A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76:585-93.
86.Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG 2000 Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? Clin Endocrinol (Oxf) 52:519-24.
87.Barbaux S, Niaudet P, Gubler MC, et al. 1997 Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467-70.
88.Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K, Yamada M 1999 Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat 14:466-70
89.Melo KF, Martin RM, Costa EM, et al. 2002 An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab 87:2500-5
90.Barbosa AS, Hadjiathanasiou CG, Theodoridis C, et al. 1999 The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 13:146-53
91.Mansour S, Hall CM, Pembrey ME, Young ID 1995 A clinical and genetic study of campomelic dysplasia. J Med Genet 32:415-20.
92.Hong JR, Barber M, Scott CI, Guttenberg M, Wolfson PJ 1995 3-Year-old phenotypic female with campomelic dysplasia and bilateral gonadoblastoma. J Pediatr Surg 30:1735-7
93.Kwok C, Weller PA, Guioli S, et al. 1995 Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal. Am J Hum Genet 57:1028-36
94.Foster JW, Dominguez-Steglich MA, Guioli S, et al. 1994 Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-30.
95.Wagner T, Wirth J, Meyer J, et al. 1994 Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-20.
96.Huang B, Wang S, Ning Y, Lamb AN, Bartley J 1999 Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet 87:349-53
97.Tate G SH, Endo Y, Mitsuya T. 2000 Assignment of desert hedgehog (DHH) to human chromosome bands 12q12-->q13.1 by in situ hybridization. . Cytogenet Cell Genet. ;88(1-2):93-4)
98.Umehara F, Tate G, Itoh K, et al. 2000 A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 67:1302-5
99.Canto P SD, Reyes E, Mendez JP. 2004 Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab.; 89(9):4480-3),
100.Lukusa T, Fryns JP, van den Berghe H 1986 Gonadoblastoma and Y-chromosome fluorescence. Clin Genet 29:311-6
101.Page DC 1987 Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101 Suppl:151-5
102.Slowikowska-Hilczer J RT, Kula K. 2003 Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl, 24(2):270-8).
103.Berthezene F, Forest MG, Grimaud JA, Claustrat B, Mornex R 1976 Leydig-cell agenesis: a cause of male pseudohermaphroditism. N Engl J Med 295:969-72.
104.Brown DM, Markland C, Dehner LP 1978 Leydig cell hypoplasia: a cause of male pseudohermaphroditism. J Clin Endocrinol Metab 46:1-7.
105.Eil C, Austin RM, Sesterhenn I, Dunn JF, Cutler GB, Jr., Johnsonbaugh RE 1984 Leydig cell hypoplasia causing male pseudohermaphroditism: diagnosis 13 years after prepubertal castration. J Clin Endocrinol Metab 58:441-8.
106.Schwartz M, Imperato-McGinley J, Peterson RE, et al. 1981 Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. J Clin Endocrinol Metab 53:123-7.
107.Lee PA, Rock JA, Brown TR, Fichman KM, Migeon CJ, Jones HW, Jr. 1982 Leydig cell hypofunction resulting in male pseudohermaphroditism. Fertil Steril 37:675-9.
108.Arnhold IJ, Mendonca BB, Bloise W, Toledo SP 1985 Male pseudohermaphroditism resulting from Leydig cell hypoplasia. J Pediatr 106:1057
109.Arnhold IJ, de Mendonca BB, Toledo SP, et al. 1987 Leydig cell hypoplasia causing male pseudohermaphroditism: case report and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 42:227-32
110.Arnhold IJ, Mendonca BB, Bisi H, et al. 1988 Normal expression of the serologically defined H-Y antigen in Leydig cell hypoplasia. J Urol 140:1549-52
111.Saldanha PH, Arnhold IJ, Mendonca BB, Bloise W, Toledo SP 1987 A clinico-genetic investigation of Leydig cell hypoplasia. Am J Med Genet 26:337-44.
112.Toledo SP, Arnhold IJ, Luthold W, Russo EM, Saldanha PH 1985 Leydig cell hypoplasia determining familial hypergonadotropic hypogonadism. Prog Clin Biol Res 200:311-4
113.Minegishi T, Nakamura K, Takakura Y, et al. 1990 Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun 172:1049-54
114.Segaloff DL, Sprengel R, Nikolics K, Ascoli M 1990 Structure of the lutropin/choriogonadotropin receptor. Recent Prog Horm Res 46:261-301; discussion 301-3
115.Kremer H, Kraaij R, Toledo SP, et al. 1995 Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160-4.
116.Laue LL, Wu SM, Kudo M, et al. 1996 Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 10:987-97.
117.Latronico AC, Anasti J, Arnhold IJ, et al. 1996 Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 334:507-12.
118.Misrahi M, Meduri G, Pissard S, et al. 1997 Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 82:2159-65
119.Martens JW, Verhoef-Post M, Abelin N, et al. 1998 A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12:775-84.
120.Zenteno JC CP, Kofman-Alfaro S, Mendez JP 1999 Evidence for genetic heterogeneity in male pseudohermaphroditism due to Leydig cell hypoplasia. J Clin Endocrinol Metab 84:3803-6.)
121.Martens J, Lumbroso S, Verhoef-Post M, et al. 2002 Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency J Clin Endocrinol Metab 87: 2506-2513.).
122.Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB 1999 Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf) 51:701-7
123.Arnhold IJ, Latronico AC, Batista MC, Carvalho FM, Chrousos GP, Mendonca BB 1997 Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility. Fertil Steril 67:394-7
124.Stavrou SS, Zhu YS, Cai LQ, et al. 1998 A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83:2091-8.
125.Laue L, Wu SM, Kudo M, et al. 1995 A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 4:1429-33
126.Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL 1998 A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-50.
127.Wu SM, Hallermeier KM, Laue L, et al. 1998 Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12:1651-60.
128.Simard J, Rheaume E, Mebarki F, et al. 1995 Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J Steroid Biochem Mol Biol 53:127-38.
129.Prader A, Gurtner HP 1955 [The syndrome of male pseudohermaphrodism in congenital adrenocortical hyperplasia without overproduction of androgens (adrenal male pseudohermaphrodism).]. Helv Paediatr Acta 10:397-412
130.Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318
131.Hauffa BP, Miller WL, Grumbach MM, Conte FA, Kaplan SL 1985 Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol (Oxf) 23:481-93
132.Lin D, Gitelman SE, Saenger P, Miller WL 1991 Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J Clin Invest 88:1955-62.
133.Bose HS, Sugawara T, Strauss JF, 3rd, Miller WL 1996 The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 335:1870-8
134.Fujieda K, Tajima T, Nakae J, et al. 1997 Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest 99:1265-71
135.Tajima T, Fujieda K, Kouda N, Nakae J, Miller WL 2001 Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86:3820-5.
136.Katsumata N OM, Hojo T, Ogawa E, Hara T, Sato N, Tanaka T. 2004 Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans).
Gender role.
137.Bongiovanni AM 1962 The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J Clin Invest 41:2086-92
138.Mason JI, Ushijima K, Doody KM, et al. 1993 Regulation of expression of the 3 beta-hydroxysteroid dehydrogenases of human placenta and fetal adrenal. J Steroid Biochem Mol Biol 47:151-9.
139.Rheaume E, Simard J, Morel Y, et al. 1992 Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat Genet 1:239-45
140.Moisan AM, Ricketts ML, Tardy V, et al. 1999 New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J Clin Endocrinol Metab 84:4410-25
141.Sutcliffe RG, Russell AJ, Edwards CR, Wallace AM 1996 Human 3 beta-hydroxysteroid dehydrogenase: genes and phenotypes. J Mol Endocrinol 17:1-5
142.Russell AJ, Wallace AM, Forest MG, Donaldson MD, Edwards CR, Sutcliffe RG 1994 Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. J Mol Endocrinol 12:225-37.
143.Mendonca BB, Russell AJ, Vasconcelos-Leite M, et al. 1994 Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol 12:119-22.
144.Mendonca BB, Bloise W, Arnhold IJ, et al. 1987 Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty. J Steroid Biochem 28:669-75.
145.Biglieri EG, Herron MA, Brust N 1966 17-hydroxylation deficiency in man. J Clin Invest 45:1946-54
146.New MI 1970 Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest 49:1930-41.
147.Yanase T, Simpson ER, Waterman MR 1991 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91-108
148.Auchus RJ 2001 The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30:101-19, vii
149.Zachmann M 1992 Recent aspects of steroid biosynthesis in male sex differentiation. Clinical studies. Horm Res 38:211-6
150.Martin RM, Lin CJ, Costa EM, et al. 2003 P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88:5739-46
151.Matteson KJ, Picado-Leonard J, Chung BC, Mohandas TK, Miller WL 1986 Assignment of the gene for adrenal P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab 63:789-91
152.Picado-Leonard J, Miller WL 1988 Homologous sequences in steroidogenic enzymes, steroid receptors and a steroid binding protein suggest a consensus steroid-binding sequence. Mol Endocrinol 2:1145-50
153.Zachmann M, Vollmin JA, Hamilton W, Prader A 1972 Steroid 17,20-desmolase deficiency: a new cause of male pseudohermaphroditism. Clin Endocrinol (Oxf) 1:369-85.
154.Geller DH, Auchus RJ, Miller WL 1999 P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol 13:167-75.
155.Saez JM, De Peretti E, Morera AM, David M, Bertrand J 1971 Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab 32:604-10.
156.Boehmer AL, Brinkmann AO, Sandkuijl LA, et al. 1999 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84:4713-21.
157.Andersson S, Moghrabi N 1997 Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 62:143-7.
158.Andersson S, Geissler WM, Wu L, et al. 1996 Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 81:130-6
159.Mendonca BB, Inacio M, Arnhold IJ, et al. 2000 Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 79:299-309.
160.Rosler A, Silverstein S, Abeliovich D 1996 A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 81:1827-31.
161.Wilson JD 2001 Androgens, androgen receptors, and male gender role behavior. Horm Behav 40:358-66.
162.Imperato-McGinley J, Peterson RE, Gautier T, Sturla E 1979 Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. N Engl J Med 300:1233-7.
163.Imperato-McGinley J, Peterson RE, Stoller R, Goodwin WE 1979 Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab 49:391-5
164.Rosler A, Kohn G 1983 Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J Steroid Biochem 19:663-74.
165.Shephard EA, Phillips IR, Santisteban I, et al. 1989 Isolation of a human cytochrome P-450 reductase cDNA clone and localization of the corresponding gene to chromosome 7q11.2. Ann Hum Genet 53 ( Pt 4):291-301
166.Hassell S, Butler MG 1994 Antley-Bixler syndrome: report of a patient and review of literature. Clin Genet 46:372-6
167.Reardon W, Smith A, Honour JW, et al. 2000 Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet 37:26-32
168.Fluck CE, Tajima T, Pandey AV, et al. 2004 Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36:228-30
169.Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C 1985 Male pseudohermaphroditism due to multiple defects in steroid- biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 313:1182-91.
170.Shackleton C, Marcos J, Arlt W, Hauffa BP 2004 Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet A 129:105-12
171.Arlt W, Walker EA, Draper N, et al. 2004 Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363:2128-35
172.Huang N, Pandey AV, Agrawal V, et al. 2005 Diversity and function of mutations in p450 oxidoreductase in patients with antley-bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76:729-49
173.Hegesh E, Hegesh J, Kaftory A 1986 Congenital methemoglobinemia with a deficiency of cytochrome b5. N Engl J Med 314:757-61
174.Giordano SJ, Kaftory A, Steggles AW 1994 A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism. Hum Genet 93:568-70
175.Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD 1974 Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291:944-9.
176.Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE 1974 Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186:1213-5.
177.Russell DW, Wilson JD 1994 Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem 63:25-61
178.Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW 1993 Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92:903-10.
179.Wigley WC, Prihoda JS, Mowszowicz I, et al. 1994 Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry 33:1265-70.
180.Thigpen AE, Davis DL, Milatovich A, et al. 1992 Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 90:799-809.
181.Andersson S, Berman DM, Jenkins EP, Russell DW 1991 Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354:159-61.
182.Mendonca BB, Inacio M, Costa EM, et al. 1996 Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 75:64-76.
183.Imperato-McGinley J 1997 5 alpha-reductase-2 deficiency. Curr Ther Endocrinol Metab 6:384-7
184.Mendonca BB IM, Costa EMF, Arnhold IJP, Russel DW, Wilson JD. . 2003 Male pseudohermaphroditism due to 5a-reductase 2 deficiency: outcome of a Brazilian cohort. Endocrinologist ; 13(3): 201-204
185.Imperato-McGinley J, Peterson RE, Gautier T, Arthur A, Shackleton C 1985 Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers. J Clin Endocrinol Metab 60:553-8.
186.Wilson JD, Griffin JE, Russell DW 1993 Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14:577-93.
187.Imperato-McGinley J, Miller M, Wilson JD, Peterson RE, Shackleton C, Gajdusek DC 1991 A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf) 34:293-8.
188.Chavez B, Valdez E, Vilchis F 2000 Uniparental disomy in steroid 5alpha-reductase 2 deficiency. J Clin Endocrinol Metab 85:3147-50.
189.Price P, Wass JA, Griffin JE, et al. 1984 High dose androgen therapy in male pseudohermaphroditism due to 5 alpha- reductase deficiency and disorders of the androgen receptor. J Clin Invest 74:1496-508.
190.Costa EM, Mendonca BB, Inacio M, Arnhold IJ, Silva FA, Lodovici O 1997 Management of ambiguous genitalia in pseudohermaphrodites: new perspectives on vaginal dilation. Fertil Steril 67:229-32.
191.Quigley CA DBA, Marschke KB, el-Awady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
192.Adachi M TR, Tomura A, Imasaki K, Kato S, Goto K, Yanase T, Ikuyama S, Nawata H . 2000 Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med. 343:856-62)
193.Morris 1953 The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol 65:1192-1211
194.Keenan BS, Meyer WJ, 3rd, Hadjian AJ, Jones HW, Migeon CJ 1974 Syndrome of androgen insensitivity in man: absence of 5 alpha- dihydrotestosterone binding protein in skin fibroblasts. J Clin Endocrinol Metab 38:1143-6.
195.Brown TR, Lubahn DB, Wilson EM, Joseph DR, French FS, Migeon CJ 1988 Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci U S A 85:8151-5.
196.Zachmann M, Prader A, Sobel EH, et al. 1986 Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls. J Pediatr 108:694-7.
197.Melo KF, Mendonca BB, Billerbeck AE, et al. 2003 Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab 88:3241-50
198.Imperato-McGinley J PR, Gautier T, Cooper G, Danner R, Arthur A, Morris PL, Sweeney WJ, Shackleton C 1982 Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency. J Clin Endocrinol Metab 54:931-41.
199.McPhaul 1999 Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 69:315-22
200.Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF, et al. 2000 Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab 85:2664-9.
201.Tint GS, Irons M, Elias ER, et al. 1994 Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107-13
202.Opitz JM 1994 RSH/SLO ("Smith-Lemli-Opitz") syndrome: historical, genetic, and developmental considerations. Am J Med Genet 50:344-6
203.Fukazawa R, Nakahori Y, Kogo T, et al. 1992 Normal Y sequences in Smith-Lemli-Opitz syndrome with total failure of masculinization. Acta Paediatr 81:570-2
204.Joseph DB, Uehling DT, Gilbert E, Laxova R 1987 Genitourinary abnormalities associated with the Smith-Lemli-Opitz syndrome. J Urol 137:719-21
205.Guerrier D, Tran D, Vanderwinden JM, et al. 1989 The persistent Mullerian duct syndrome: a molecular approach. J Clin Endocrinol Metab 68:46-52
206.Opitz JM, Gilbert-Barness E, Ackerman J, Lowichik A 2002 Cholesterol and development: the RSH ("Smith-Lemli-Opitz") syndrome and related conditions. Pediatr Pathol Mol Med 21:153-81
207.Josso N, di Clemente N, Gouedard L 2001 Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol 179:25-32.
208.Josso N 1995 Paediatric applications of anti-mullerian hormone research. 1992 Andrea Prader Lecture. Horm Res 43:243-8
209.Cohen-Haguenauer O, Picard JY, Mattei MG, et al. 1987 Mapping of the gene for anti-mullerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 44:2-6
210.Josso N, di Clemente N 1999 TGF-beta Family Members and Gonadal Development. Trends Endocrinol Metab 10:216-222.
211.Guerrier D, Tran D, Vanderwinden JM, et al. 1989 The persistent Mullerian duct syndrome: a molecular approach. J Clin Endocrinol Metab 68:46-52.
212.Imbeaud S, Faure E, Lamarre I, et al. 1995 Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor. Nat Genet 11:382-8.
213.Imbeaud S, Carre-Eusebe D, Rey R, Belville C, Josso N, Picard JY 1994 Molecular genetics of the persistent mullerian duct syndrome: a study of 19 families. Hum Mol Genet 3:125-31.
214.Loeff DS, Imbeaud S, Reyes HM, Meller JL, Rosenthal IM 1994 Surgical and genetic aspects of persistent mullerian duct syndrome. J Pediatr Surg 29:61-5.
215.Aarskog D 1979 Maternal progestins as a possible cause of hypospadias. N Engl J Med 300:75-8
216.Driscoll SG, Taylor SH 1980 Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol 56:537-42
217.Fredell L, Lichtenstein P, Pedersen NL, Svensson J, Nordenskjold A 1998 Hypospadias is related to birth weight in discordant monozygotic twins. J Urol 160:2197-9
218.Francois I, van Helvoirt M, de Zegher F 1999 Male pseudohermaphroditism related to complications at conception, in early pregnancy or in prenatal growth. Horm Res 51:91-5
219.Mendonca BB, Billerbeck AE, de Zegher F 2001 Nongenetic male pseudohermaphroditism and reduced prenatal growth. N Engl J Med 345:1135.
220.Costa EMF, Correa RV, Mello KFAS, Arnhold IJ, Mendonca BB 2001 Male pseudohemaphroditism associated with low birthweight. Pediatric Research 49:57A
221.Morel Y, Rey R, Teinturier C, et al. 2002 Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 161:49-59.
222.Hussain N, Chaghtai A, Herndon CD, Herson VC, Rosenkrantz TS, McKenna PH 2002 Hypospadias and early gestation growth restriction in infants. Pediatrics 109:473-8
223.Michel A, Mormont C, Legros JJ 2001 A psycho-endocrinological overview of transsexualism. Eur J Endocrinol 145:365-76
224.Baker HJ, Green R 1970 Treatment of transsexualism. Curr Psychiatr Ther 10:88-99
225.Schlatterer K, Yassouridis A, von Werder K, Poland D, Kemper J, Stalla GK 1998 A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients. Arch Sex Behav 27:475-92.
226.Moore E, Wisniewski A, Dobs A 2003 Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88:3467-73
227.Migeon CJ, Wisniewski AB 1998 Sexual differentiation: from genes to gender. Horm Res 50:245-51
228.Meyer-Bahlburg HF 1994 Intersexuality and the diagnosis of gender identity disorder. Arch Sex Behav 23:21-40.
229.Meyer-Bahlburg HF 1984 Psychoendocrine research on sexual orientation. Current status and future options. Prog Brain Res 61:375-98
230.Denes FT, Mendonca BB, Arap S 2001 Laparoscopic management of intersexual states. Urol Clin North Am 28:31-42.
231.Denes FT, Cocuzza MA, Schneider-Monteiro ED, et al. 2005 The laparoscopic management of intersex patients: the preferred approach. BJU Int 95:863-7
232.Katz MD, Kligman I, Cai LQ, et al. 1997 Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency. N Engl J Med 336:994-7.